These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer. Mimatsu K, Oida T, Fukino N, Kano H, Kawasaki A, Kida K, Kuboi Y, Amano S. Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683 [Abstract] [Full Text] [Related]
5. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer. Hefler-Frischmuth K, Seebacher V, Polterauer S, Tempfer C, Reinthaller A, Hefler L. Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329 [Abstract] [Full Text] [Related]
6. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. Hirashima K, Watanabe M, Shigaki H, Imamura Y, Ida S, Iwatsuki M, Ishimoto T, Iwagami S, Baba Y, Baba H. J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018 [Abstract] [Full Text] [Related]
7. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Tian R, Zhang F, Sun P, Wu J, Yan H, Wu AR, Zhang M, Jiang YL, Lu YH, Xu QY, Zhan XH, Zhang RX, Qian LT, He J. Oncotarget; 2016 Oct 11; 7(41):67485-67494. PubMed ID: 27528228 [Abstract] [Full Text] [Related]
12. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ishizuka M, Nagata H, Takagi K, Kubota K. Ann Surg; 2009 Aug 11; 250(2):268-72. PubMed ID: 19638907 [Abstract] [Full Text] [Related]
13. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy. Chen P, Fang M, Wan Q, Zhang X, Song T, Wu S. Oncotarget; 2017 Nov 21; 8(59):99861-99870. PubMed ID: 29245945 [Abstract] [Full Text] [Related]
14. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A. Bone Joint J; 2015 Jun 21; 97-B(6):847-52. PubMed ID: 26033068 [Abstract] [Full Text] [Related]
15. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Miki C, Kusunoki M. Oncology; 2013 Jun 21; 84(2):100-7. PubMed ID: 23147449 [Abstract] [Full Text] [Related]
16. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer? Walsh SM, Casey S, Kennedy R, Ravi N, Reynolds JV. J Surg Oncol; 2016 Jun 21; 113(7):732-7. PubMed ID: 27004839 [Abstract] [Full Text] [Related]
17. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Nakayama M, Tabuchi K, Hara A. Head Neck; 2015 Dec 21; 37(12):1745-9. PubMed ID: 24989115 [Abstract] [Full Text] [Related]
19. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Anticancer Res; 2016 Mar 21; 36(3):995-1001. PubMed ID: 26976989 [Abstract] [Full Text] [Related]